Haberman Management Corp is a New York money management firm that has successfully managed small-cap funds for nearly two decades and now focuses on family funds. It supports charitable causes such as the Ovarian Cancer Research Fund, which provides grants to researchers studying ovarian cancer. A recent OCRF grant helped researchers at Case Western Reserve University identify a biomarker involved in tumor growth and treatment resistance that could allow doctors to better predict patients' responses to cancer therapies and improve treatment outcomes.

1. By Haberman Management Corp

2. 
Haberman Management Corp., a New York
money management firm, maintained nearly
two decades of success in small-cap fund
investments and now concentrates on
managing family funds. Diligent in utilizing
resources to support charitable
causes, Haberman Management Corp.
contributes to such organizations as the
Ovarian Cancer Research Fund (OCRF), a
group dedicated to fighting the disease
through innovative research and medical
advances.

3. 
OCRF provides grants to leading physicians
and researchers to fund more in-depth and
focused studies. A recent OCRF grantee led a
team of researchers at Case Western Reserve
University in a study whose findings have the
potential to allow doctors to predict how
certain women respond to cancer treatments
and improve the likelihood of their
treatment’s success.

4. 
Researchers identified a biomarker that is
involved in activating tumor cells, causing the
disease to progress and resist treatments. By
identifying the miR-181a microRNA in
women with ovarian cancer, researchers hope
doctors can make more informed decisions
about what type of treatment is best for those
women. Visit www.ocrf.org for more news
about ovarian cancer research.